Text Size
308 studies found for:    colorectal | Recruiting | Exclude Unknown | United States

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Conditions: Colorectal Neoplasms;   Digestive System Diseases;   Colonic Diseases;   Colorectal Cancer
Intervention:
2 Recruiting Ohio Colorectal Cancer Prevention Initiative
Conditions: Lynch Syndrome;   Colorectal Cancer
Interventions: Genetic: LS tumor screening;   Genetic: Genetic testing;   Behavioral: Genetic Counseling;   Other: Biorepository;   Behavioral: Questionnaire
3 Recruiting A Trial of Metformin for Colorectal Cancer Risk Reduction Among Patients With a History of Colorectal Adenomas and Elevated Body Mass Index
Conditions: Adenomatous Polyp;   Colorectal Cancer;   Obesity
Interventions: Drug: metformin hydrochloride;   Other: pharmacological study;   Other: laboratory biomarker analysis
4 Recruiting Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease (IBD);   Primary Sclerosing Cholangitis (PSC);   Colorectal Neoplasms;   Colorectal Cancer
Intervention:
5 Recruiting Adjuvant Aflibercept for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Aflibercept
6 Recruiting RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Condition: Colorectal Cancer
Interventions: Drug: RAD011;   Drug: FOLFOX;   Drug: Bevacizumab
7 Recruiting Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
Conditions: Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage I Colon Cancer;   Stage I Rectal Cancer
Interventions: Dietary Supplement: cholecalciferol;   Procedure: biopsy;   Genetic: protein expression analysis;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis;   Genetic: reverse transcriptase-polymerase chain reaction
8 Recruiting Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
Condition: Colorectal Cancer
Interventions: Procedure: Colonoscopy;   Procedure: FIT
9 Recruiting Decision Aid to Technologically Enhance Shared Decision Making
Condition: Colorectal Cancer
Intervention: Behavioral: Colorectal Web
10 Recruiting NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: NKTR-102;   Drug: irinotecan
11 Recruiting FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
Condition: Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Leucovorin;   Drug: 5-Fluorouracil
12 Recruiting Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
Condition: Colorectal Neoplasms
Interventions: Drug: Placebo;   Drug: Metformin
13 Recruiting Dose Finding Study of Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Colon Cancer;   Rectal Cancer
Intervention: Drug: IMMU-130
14 Recruiting Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Conditions: Colorectal Carcinoma;   CRC
Interventions: Biological: JX-594;   Drug: Irinotecan
15 Recruiting Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Imprime PGG + cetuximab;   Drug: Cetuximab
16 Recruiting Exercise and Metformin in Colorectal and Breast Cancer Survivors
Conditions: Colorectal Cancer;   Breast Cancer
Interventions: Behavioral: Exercise training;   Drug: Exercise training plus metformin;   Drug: Metformin;   Other: Educational information
17 Recruiting Phase 2A Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
Conditions: Metastatic Pancreatic Cancer;   Metastatic Colorectal Cancer
Intervention: Drug: NPC-1C/NEO-102
18 Recruiting A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss
Conditions: Metastatic Colorectal Cancer;   Cachexia;   Weight Loss
Interventions: Drug: MABp1;   Drug: Megestrol Acetate
19 Recruiting A Study in Second Line Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Ramucirumab;   Drug: Irinotecan;   Biological: Placebo;   Drug: Folinic Acid;   Drug: 5-Fluorouracil
20 Recruiting Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
Condition: Colorectal Cancer
Interventions: Drug: GS-6624;   Drug: FOLFIRI;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years